Memory consolidation — Mechanisms and opportunities for enhancement
Tóm tắt
Memory consolidation is the process by which relevant information is selected and transferred from a short-term, fragile state, into a stable, longer term domain from which it can be recalled. Effective memory underpins our ability to carry out everyday activities. When memory consolidation fails, such as in Alzheimer’s disease, the consequences can be devastating. Understanding the neurobiology of memory will help develop treatments for patients with memory loss. Here we describe the myriad processes involved in memory consolidation, including cholinergic and dopaminergic neurotransmission predominantly in hippocampal networks. We discuss established therapies as well as potential novel strategies for boosting cognition. Future approaches to enhancement of memory consolidation include not only pharmacological and neurosurgical treatments, but also lifestyle interventions — for example, modifications to sleep, exercise and diet.
Tài liệu tham khảo
Launer L.J., Andersen K., Dewey M.E., Letenneur L., Ott A., Amaducci L.A., et al., Rates and risk factors for dementia and Alzheimer’s disease — Results from EURODEM pooled analyses, Neurology, 1999, 52, 78–84
Braak H., Braak E., Staging of Alzheimer’s disease-related neurofibrillary changes, Neurobiol. Aging, 1995, 16, 271–278
Schuff N., Woerner N., Boreta L., Kornfield T., Shaw L.M., Trojanowski J.Q., et al., MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers, Brain, 2009, 132, 1067–1077
McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., et al., The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement., 2011, 7, 263–269
Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., et al., Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis, Brain, 2004, 127, 701–712
Spencer R.M.C., Gouw A.M., Ivry R.B., Age-related decline of sleepdependent consolidation, Learn. Mem., 2007, 14, 480–484
Buzsáki G., Two-stage model of memory trace formation — a role for “noisy” brain states, Neuroscience, 1989, 31, 551–570
Rasch B., Born J., Maintaining memories by reactivation, Curr. Opin. Neurobiol., 2007, 17, 698–703
Stickgold R., James L., Hobson J.A., Visual discrimination learning requires sleep after training, Nat. Neurosci., 2000, 3, 1237–1238
Fischer S., Hallschmid M., Elsner A.L., Born J., Sleep forms memory for finger skills, Proc. Natl. Acad. Sci. USA, 2002, 99, 11987–11991
Rasch B., Buechel C., Gais S., Born J., Odor cues during slow-wave sleep prompt declarative memory consolidation, Science, 2007, 315, 1426–1429
Buzsáki G., Hippocampal sharp waves — their origin and significance, Brain Res., 1986, 398, 242–252
Behrens C.J., van den Boom L.P., de Hoz L., Friedman A., Heinemann U., Induction of sharp wave-ripple complexes in vitro and reorganization of hippocampal networks, Nat. Neurosci., 2005, 8, 1560–1567
Sirota A., Csicsvari J., Buhl D., Buzsáki G., Communication between neocortex and hippocampus during sleep in rodents, Proc. Natl. Acad. Sci. USA, 2003, 100, 2065–2069
Ji D., Wilson M.A., Coordinated memory replay in the visual cortex and hippocampus during sleep, Nat. Neurosci., 2007, 10, 100–107
Peyrache A., Khamassi M., Benchenane K., Wiener S.I., Battaglia F.P., Replay of rule-learning related neural patterns in the prefrontal cortex during sleep, Nat. Neurosci., 2009, 12, 919–926
Gauthier S., Scheltens P., Can we do better in developing new drugs for Alzheimer’s disease?, Alzheimers Dement., 2009, 5, 489–491
Bartus R.T., Dean R.L., Beer B., Lippa A.S., The cholinergic hypothesis of geriatric memory dysfunction, Science, 1982, 217, 408–417
Davies P., Maloney A.J.F., Selective loss of central cholinergic neurons in Alzheimer’s disease, Lancet, 1976, 2, 1403–1403
Drachman D.A., Leavitt J., Human memory and cholinergic system — relationship to aging, Arch. Neurol., 1974, 30, 113–121
Ellis B.W., Johns M.W., Lancaster R., Raptopoulos P., Angelopoulos N., Priest R.G., The St. Mary’s Hospital sleep questionnaire: a study of reliability, Sleep, 1981, 4, 93–97
Bodick N.C., Offen W.W., Levey A.I., Cutler N.R., Gauthier S.G., Satlin A., et al., Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease, Arch. Neurol., 1997, 54, 465–473
Levey A.I., Immunological localization of m1-m5 muscarinic acetylcholine-receptors in peripheral-tissues and brain, Life Sci., 1993, 52, 441–448
Roldán G., Bolaños-Badillo E., González-Sánchez H., Quirarte G.L., Prado-Alcalá R.A., Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats, Neurosci. Lett., 1997, 230, 93–96
Ferreira A.R., Fürstenau L., Blanco C., Kornisiuk E., Sánchez G., Daroit D., et al., Role of hippocampal M-1 and M-4 muscarinic receptor subtypes in memory consolidation in the rat, Pharmacol. Biochem. Behav., 2003, 74, 411–415
Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., et al., Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice, Nat. Neurosci., 2003, 6, 51–58
Nissen C., Power A.E., Noftinger E.A., Feige B., Voderholzer U., Kloepfer C., et al., M-1 muscarinic acetylcholine receptor agonism alters sleep without affecting memory consolidation, J. Cogn. Neurosci., 2006, 18, 1799–1807
Foster N.L., Aldrich M.S., Bluemlein L., White R.F., Berent S., Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep, Neurology, 1989, 39, 257–261
Deuschl G., Schade-Brittinger C., Krack P., Volkmann J., Schäfer H., Bötzel K., et al., A randomized trial of deep-brain stimulation for Parkinson’s disease, N. Engl. J. Med., 2006, 355, 896–908
Huys D., Möller M., Kim E.H., Hardenacke K., Huff W., Klosterkötter J., et al., Deep brain stimulation for psychiatric disorders: historical basis, Nervenarzt, 2012, 83, 1156–1168
Laxton A.W., Tang-Wai D.F., McAndrews M.P., Zumsteg D., Wennberg R., Keren R., et al., A phase I trial of deep brain stimulation of memory circuits in Alzheimer’s Disease, Ann. Neurol., 2010, 68, 521–534
Suthana N., Haneef Z., Stern J., Mukamel R., Behnke E., Knowlton B., et al., Memory enhancement and deep-brain stimulation of the entorhinal area, N. Engl. J. Med., 2012, 366, 502–510
Bethus I., Tse D., Morris R.G.M., Dopamine and memory: modulation of the persistence of memory for novel hippocampal NMDA receptordependent paired associates, J. Neurosci., 2010, 30, 1610–1618
Chowdhury R., Guitart-Masip M., Bunzeck N., Dolan R.J., Düzel E., Dopamine modulates episodic memory persistence in old age, J. Neurosci., 2012, 32, 14193–14204
Coulthard E.J., Bogacz R., Javed S., Mooney L.K., Murphy G., Keeley S., et al., Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making, Brain, 2012, 135, 3721–3734
Lisman J., Grace A.A., Düzel E., A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP, Trends Neurosci., 2011, 34, 536–547
Bernabeu R., Bevilaqua L., Ardenghi P., Bromberg E., Schmitz P., Bianchin M., et al., Involvement of hippocampal cAMP/cAMPdependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats, Proc. Natl. Acad. Sci. USA, 1997, 94, 7041–7046
Hannestad J., Gallezot J.-D., Planeta-Wilson B., Lin S.-F., Williams W.A., van Dyck C.H., et al., Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo, Biol. Psychiatry, 2010, 68, 854–860
Volkow N.D., Fowler J.S., Wang G., Ding Y., Gatley S.J., Mechanism of action of methylphenidate: insights from PET imaging studies, J. Atten. Disord., 2002, 6,Suppl. 1, S31–43
Andersen M.L., Kessler E., Murnane K.S., McClung J.C., Tufik S., Howell L.L., Dopamine transporter-related effects of modafinil in rhesus monkeys, Psychopharmacology, 2010, 210, 439–448
Outram S.M., The use of methylphenidate among students: the future of enhancement?, J. Med. Ethics, 2010, 36, 198–202
Turner D.C., Robbins T.W., Clark L., Aron A.R., Dowson J., Sahakian B.J., Cognitive enhancing effects of modafinil in healthy volunteers, Psychopharmacology, 2003, 165, 260–269
Linssen A.M.W., Vuurman E.F.P.M., Sambeth A., Riedel W.J., Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers, Psychopharmacology, 2012, 221, 611–619
Berridge C.W., Devilbiss D.M., Psychostimulants as cognitive Enhancers: the prefrontal cortex, catecholamines, and attentiondeficit/ hyperactivity disorder, Biol. Psychiatry, 2011, 69, E101–111
Pierard C., Liscia P., Chauveau F., Coutan M., Corio M., Krazem A., et al., Differential effects of total sleep deprivation on contextual and spatial memory: modulatory effects of modafinil, Pharmacol. Biochem. Behav., 2011, 97, 399–405
Müller U., Rowe J.B., Rittman T., Lewis C., Robbins T.W., Sahakian B.J., Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers, Neuropharmacology, 2013, 64, 490–495
Scammell T.E., Estabrooke I.V., McCarthy M.T., Chemelli R.M., Yanagisawa M., Miller M.S., et al., Hypothalamic arousal regions are activated during modafinil-induced wakefulness, J. Neurosci., 2000, 20, 8620–8628
Meneses A., Ponce-Lopez T., Tellez R., Gonzalez R., Castillo C., Gasbarri A., Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats, Behav. Brain Res., 2011, 216, 472–476
Wiig K.A., Whitlock J.R., Epstein M.H., Carpenter R.L., Bear M.F., The levo enantiomer of amphetamine increases memory consolidation and gene expression in the hippocampus without producing locomotor stimulation, Neurobiol. Learn. Mem., 2009, 92, 106–113
Ballard M.E., Gallo D.A., de Wit H., THC impairs, and amphetamine facilitates, memory encoding preferentially for emotionally salient stimuli, Soc. Neurosci. Abstr., 2011, 41, 752.06
Advokat C., Scheithauer M., Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers, Front. Neurosci., 2013, 7, 82
Sumowski J.F., Chiaravalloti N.D., Erlanger D.M., Kaushik T., Benedict R., DeLuca J., L-amphetamine improves memory capacity among memory-impaired patients with multiple sclerosis, Neurology, 2011, 76,Suppl. 4, A482
Jones S., Kornblum J.L., Kauer J.A., Amphetamine blocks long-term synaptic depression in the ventral tegmental area, J. Neurosci., 2000, 20, 5575–5580
Del Arco A., González-Mora J.L., Armas V.R., Mora F., Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms, Neuropharmacology, 1999, 38, 943–954
Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., et al., Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria, Biol. Psychiatry, 2001, 49, 81–96
Imperato A., Obinu M.C., Gessa G.L., Effects of cocaine and amphetamine on acetylcholine-release in the hippocampus and caudate nucleus, Eur. J. Pharmacol., 1993, 238, 377–381
Day J.C., Fibiger H.C., Dopaminergic regulation of septohippocampal cholinergic neurons, J. Neurochem., 1994, 63, 2086–2092
Ponomarenko A.A., Lin J.S., Selbach O., Haas H.L., Temporal pattern of hippocampal high-frequency oscillations during sleep after stimulant-evoked waking, Neuroscience, 2003, 121, 759–769
Bekinschtein P., Cammarota M., Igaz L.M., Bevilaqua L.R.M., Izquierdo I., Medina J.H., Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus, Neuron, 2007, 53, 261–277
Rossato J.I., Bevilaqua L.R.M., Izquierdo I., Medina J.H., Cammarota M., Dopamine controls persistence of long-term memory storage, Science, 2009, 325, 1017–1020
Pencea V., Bingaman K.D., Wiegand S.J., Luskin M.B., Infusion of brainderived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus, J. Neurosci., 2001, 21, 6706–6717
Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., et al., Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease, Nat. Med., 2009, 15, 331–337
Patel N.K., Gill S.S., GDNF delivery for Parkinson’s disease, Acta Neurochir. Suppl., 2007, 97, 135–154
Donlea J.M., Thimgan M.S., Suzuki Y., Gottschalk L., Shaw P.J., Inducing sleep by remote control facilitates memory consolidation in Drosophila, Science, 2011, 332, 1571–1576
Mathias S., Zihl J., Steiger A., Lancel M., Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects, Neuropsychopharmacology, 2005, 30, 833–841
Faulhaber J., Steiger A., Lancel M., The GABA(A) agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans, Psychopharmacology, 1997, 130, 285–291
Boyle J., Wolford D., Gargano C., McCrea J., Cummings C., Cerchio K., et al., Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects, Hum. Psychopharmacol., 2009, 24, 61–71
Dijk D.J., James L.M., Peters S., Walsh J.K., Deacon S., Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep, J. Psychopharmacol., 2010, 24, 1613–1618
Massimini M., Ferrarelli F., Esser S.K., Riedner B.A., Huber R., Murphy M., et al., Triggering sleep slow waves by transcranial magnetic stimulation, Proc. Natl. Acad. Sci. USA, 2007, 104, 8496–8501
Marshall L., Helgadottir H., Moelle M., Born J., Boosting slow oscillations during sleep potentiates memory, Nature, 2006, 444, 610–613
Toni G., Riedner B.A., Hulse B.K., Ferrarelli F., Sarasso S., Enhancing sleep slow waves with natural stimuli, Medicamundi, 2010, 54, 73–79
Ngo H.-V.V., Martinetz T., Born J., Moelle M., Auditory closed-loop stimulation of the sleep slow oscillation enhances memory, Neuron, 2013, 78, 545–553
van Praag H., Christie B.R., Sejnowski T.J., Gage F.H., Running enhances neurogenesis, learning, and long-term potentiation in mice, Proc. Natl. Acad. Sci. USA, 1999, 96, 13427–13431
van Praag H., Neurogenesis and exercise: past and future directions, Neuromolecular Med., 2008, 10, 128–140
Berggren K.L., Kerr A.L., Iles B.W., Nye S.H., Swain R.A., Exerciseinduced angiogenesis in the CNS of Dahl Salt-Sensitive and SSBN.13 consomic rats, Soc. Neurosci. Abstr., 2008, 38, 219.10
Chaddock L., Erickson K.I., Prakash R.S., Kim J.S., Voss M.W., VanPatter M., et al., A neuroimaging investigation of the association between aerobic fitness, hippocampal volume, and memory performance in preadolescent children, Brain Res., 2010, 1358, 172–183
Erickson K.I., Voss M.W., Prakash R.S., Basak C., Szabo A., Chaddock L., et al., Exercise training increases size of hippocampus and improves memory, Proc. Natl. Acad. Sci. USA, 2011, 108, 3017–3022
Coles K., Tomporowski P.D., Effects of acute exercise on executive processing, short-term and long-term memory, J. Sports Sci., 2008, 26, 333–344
Gould E., Reeves A.J., Fallah M., Tanapat P., Gross C.G., Fuchs E., Hippocampal neurogenesis in adult Old World primates, Proc. Nat. Acad. Sci. USA, 1999, 96, 5263–5267
Amrein I., Isler K., Lipp H.-P., Comparing adult hippocampal neurogenesis in mammalian species and orders: influence of chronological age and life history stage, Eur. J. Neurosci., 2011, 34, 978–987
Apostolova L.G., Green A.E., Babakchanian S., Hwang K.S., Chou Y.-Y., Toga A.W., et al., Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer disease, Alzheimer Dis. Assoc. Disord., 2012, 26, 17–27
Garcia-Mesa Y., Carlos Lopez-Ramos J., Gimenez-Llort L., Revilla S., Guerra R., Gruart A., et al., Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice, J. Alzheimers Dis., 2011, 24, 421–454
Rodriguez J.J., Noristani H.N., Olabarria M., Fletcher J., Somerville T.D.D., Yeh C.Y., et al., Voluntary running and environmental enrichment restores impaired hippocampal neurogenesis in a triple transgenic mouse model of Alzheimer’s disease, Curr. Alzheimer Res., 2011, 8, 707–717
Nagamatsu L.S., Chan A., Davis J.C., Beattie J.C., Beattie B.L., Graf P., et al., Physical activity improves verbal and spatial memory in older adults with probable mild cognitive impairment: a 6-month randomized controlled trial, J. Aging Res., 2013, 861893
Lautenschlager N.T., Cox K.L., Flicker L., Foster J.K., van Bockxmeer F.M., Xiao J., et al., Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial, JAMA, 2008, 300, 1027–1037
Cassilhas R.C., Lee K.S., Fernandes J., Oliveira M.G.M., Tufik S., Meeusen R., et al., Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms, Neuroscience, 2012, 202, 309–317
Chen D.Y., Stern S.A., Garcia-Osta A., Saunier-Rebori B., Pollonini G., Bambah-Mukku D., et al., A critical role for IGF-II in memory consolidation and enhancement, Nature, 2011, 469, 491–497
Dash M.B., Bellesi M., Tononi G., Cirelli C., Sleep/wake dependent changes in cortical glucose concentrations, J. Neurochem., 2013, 124, 79–89
Jones E.K., Suenram-Lea S.I., Wesnes K.A., Acute ingestion of different macronutrients differentially enhances aspects of memory and attention in healthy young adults, Biol. Psychol., 2012, 89, 477–486
Messier C., Glucose improvement of memory: a review, Eur. J. Pharmacol., 2004, 490, 33–57
Smith M.A., Riby L.M., van Eekelen J.A.M., Foster J.K., Glucose enhancement of human memory: a comprehensive research review of the glucose memory facilitation effect, Neurosci. Biobehav. Rev., 2011, 35, 770–783
Sunram-Lea S.I., Foster J.K., Durlach P., Perez C., Glucose facilitation of cognitive performance in healthy young adults: examination of the influence of fast-duration, time of day and pre-consumption plasma glucose levels, Psychopharmacology, 2001, 157, 46–54
Sunram-Lea S.I., Foster J.K., Durlach P., Perez C., Investigation into the significance of task difficulty and divided allocation of resources on the glucose memory facilitation effect, Psychopharmacology, 2002, 160, 387–397
Sunram-Lea S.I., Foster J.K., Durlach P., Perez C., The effect of retrograde and anterograde glucose administration on memory performance in healthy young adults, Behav. Brain Res., 2002, 134, 505–516
Varady K.A., Hellerstein M.K., Alternate-day fasting and chronic disease prevention: a review of human and animal trials, Am. J. Clin. Nutr., 2007, 86, 7–13
Partridge L., Piper M.D.W., Mair W., Dietary restriction in Drosophila, Mech. Ageing Dev., 2005, 126, 938–950
Mattison J.A., Roth G.S., Beasley T.M., Tilmont E.M., Handy A.M., Herbert R.L., et al., Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study, Nature, 2012, 489, 318–321
Weindruch R., Walford R.L., Fligiel S., Guthrie D., The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy-intake, J. Nutr., 1986, 116, 641–654
Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., et al., Caloric restriction delays disease onset and mortality in rhesus monkeys, Science, 2009, 325, 201–204
Eckles-Smith K., Clayton D., Bickford P., Browning M.D., Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression, Mol. Brain Res., 2000, 78, 154–162
Singh R., Lakhanpal D., Kumar S., Sharma S., Kataria H., Kaur M., et al., Late-onset intermittent fasting dietary restriction as a potential intervention to retard age-associated brain function impairments in male rats, Age, 2012, 34, 917–933
Qin W., Chachich M., Lane M., Roth G., Bryant M., de Cabo R., et al., Calorie restriction attenuates Alzheimer’s disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus), J. Alzheimers Dis., 2006, 10, 417–422
Wu P., Shen Q., Dong S., Xu Z., Tsien J.Z., Hu Y., Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice, Neurobiol. Aging, 2008, 29, 1502–1511
Thaler S., Choragiewicz T.J., Rejdak R., Fiedorowicz M., Turski W.A., Tulidowicz-Bielak M., et al., Neuroprotection by acetoacetate and beta-hydroxybutyrate against NMDA-induced RGC damage in ratpossible involvement of kynurenic acid, Graefes Arch. Clin. Exp. Ophthal., 2010, 248, 1729–1735
Henderson S.T., Ketone bodies as a therapeutic for Alzheimer’s disease, Neurotherapeutics, 2008, 5, 470–480
Reger M.A., Henderson S.T., Hale C., Cholerton B., Baker L.D., Watson G.S., et al., Effects of beta-hydroxybutyrate on cognition in memoryimpaired adults, Neurobiol. Aging, 2004, 25, 311–314
Dhurandhar E.J., Allison D.B., van Groen T., Kadish I., Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer’s disease pathology in a mouse model, PLoS One, 2013, 8, e60437
Cao D.H., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., et al., Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function, J. Neurochem., 2009, 111, 510–521
Bhatia H.S., Agrawal R., Sharma S., Huo Y.-X., Ying Z., Gomez-Pinilla F., Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood, PLoS One, 2011, 6, e28451
Vines A., Delattre A.M., Lima M.M.S., Rodrigues L.S., Suchecki D., Machado R.B., et al., The role of 5-HT1A receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism, Neuropharmacology, 2012, 62, 184–191
Arsenault D., Julien C., Tremblay C., Calon F., DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice, PLoS One, 2011, 6, e17397